GCV Asia Congress 2018
Skip Content

12 October 2017

Rimasys performs seed round

The surgical model developer, based on research at German Sport University College and University Hospital of Cologne, will use the cash to enter North American and Asian markets.

Author: Callum Cyrus, reporter

Rimasys, a Germany-based surgical model developer, received an undisclosed amount of seed funding from public-private partnership High-Tech Gründerfonds (HTGF) on Tuesday.

Rimasys was spun out from the Institute of Biomechanics and Orthopaedics at German Sports University Cologne in 2016. The company also exploits research conducted at University Hospital of Cologne.

The spinout has developed technology that uses a machine-learning algorithm and device to generate authentic models of human fracture points on the limbs with soft tissue overlays – enabling surgeons and implant manufacturers to practice without opening up a real patient.

HTGF’s funding will help expand Rimasys’s range to cover the hip, spine and the areas surrounding the head and neck.

Rimasys is also preparing international expansions into North America and Asia in 2018, after taking first orders from Germany, Switzerland and Australia this year.

Philipp Rittershaus, an investment manager at HTGF, added: “The team collects unique datasets which enable further business models around digital learning, implant development and even in adjacent industries like safety systems in automotive or preventive sportswear.

“These upside opportunities will be explored along with our seed investment.”

Copyright Mawsonia Limited 2010. Please don´t cut articles from www.globaluniversityventuring.com or the PDF and redistribute by email or post to the web without written permission.

  • Linkedin
  • Mail
  • Rssfeed